Vaniambadi S. Kalyanaraman

Author

Advanced Bioscience Laboratories (United States)

Also Known As

V C Kalyanaraman, V KALYANARAMAN, V Kalyanaraman, V S Kalyanaraman, V. S. KALYANARAMAN, V. S. Kalyanaraman, V.S. KALYANARAMAN, V.S. Kalyanaraman, VANIAMBADI S. KALYANARAMAN, Vaniambadi Kalyanaraman

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Advanced Bioscience Laboratories (United States)BioScience Laboratories (United States)North Shore University Hospital National Cancer Institute Cornell University

About

Vaniambadi S. Kalyanaraman is an author at Advanced Bioscience Laboratories (United States) specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	33	1.9K
2	Cell Biology	8	8	467
3	Allergy	3	3	227
4	Biomolecular Engineering	2	2	109
5	Biochemistry	1	1	73

Vaniambadi S. Kalyanaraman

Publications

Citations

H-Index

Page 1

	Year	Citations
Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV) J. Steven McDougal, S P Cort, Melanie S. Kennedy, Journal of Immunological Methods VaccinationDiagnostic VirologyViral PersistenceViral DiagnosticsHuman Retrovirus	1985	207
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition Monica Vaccari, Shari N. Gordon, Slim Fourati, Nature Medicine Adaptive Immune SystemPathogenesisImmunologyAdjuvant-dependent InnateInnate Immune System	2016	203
Subunit Recombinant Vaccine Protects against Monkeypox Jean‐Michel Héraud, Yvette Edghill‐Smith, Victor I. Ayala, The Journal of Immunology	2006	181
Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy Mikuláš Popovič, Klara Tenner‐Racz, Colleen Pelser, Proceedings of the National Academy of Sciences Viral ReplicationImmunologyImmunodominanceHiv-1 PersistenceViral Persistence	2005	163
Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Naoki Oyaizu, Narendra Chirmule, Vaniambadi S. Kalyanaraman, Proceedings of the National Academy of Sciences T-regulatory CellImmune RegulationImmunologyEnvelope Glycoprotein Gp120Immunologic Mechanism	1990	143
Correlation of Vaccine-Elicited Systemic and Mucosal Nonneutralizing Antibody Activities with Reduced Acute Viremia following Intrarectal Simian Immunodeficiency Virus SIV <sub>mac251</sub> Challenge of Rhesus Macaques Rachmat Hidajat, Peng Xiao, Qifeng Zhou, Journal of Virology	2008	123
Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160 Thomas C. VanCott, John R. Mascola, Robert W. Kaminski, Journal of Virology ImmunologyAntigen ProcessingImmunotherapyPrimary Hiv-1 IsolatesNeutralization Activity	1997	112
HIV-1 Neutralizing Antibodies in the Genital and Respiratory Tracts of Mice Intranasally Immunized with Oligomeric gp160 Thomas C. VanCott, Robert W. Kaminski, John R. Mascola, The Journal of Immunology Candidate Hiv-1 VaccineImmunologyImmunodominanceImmunotherapyHuman Retrovirus	1998	111
Replicating Adenovirus-Simian Immunodeficiency Virus (SIV) Recombinant Priming and Envelope Protein Boosting Elicits Localized, Mucosal IgA Immunity in Rhesus Macaques Correlated with Delayed Acquisition following a Repeated Low-Dose Rectal SIV <sub>mac251</sub> Challenge Peng Xiao, L. Jean Patterson, Seraphin Kuate, Journal of Virology ImmunodeficienciesImmunologyViral PathogenesisImmunodominanceAdenovirus-simian Immunodeficiency Virus	2012	93
Modulation of Bcl-2 Protein by CD4 Cross-Linking: A Possible Mechanism for Lymphocyte Apoptosis in Human Immunodeficiency Virus Infection and for Rescue of Apoptosis by Interleukin-2 Futoshi Hashimoto, Naoki Oyaizu, Vaniambadi S. Kalyanaraman, Blood	1997	84

Page 1